Repligen to report Q2 2026 financial results on July 28
Repligen Corporation will announce its Q2 2026 financial results on July 28, 2026, followed by a conference call at 8:00 a.m. ET. The results will cover the period ended June 30, 2026.
*this image is generated using AI for illustrative purposes only.
Repligen Corporation will announce its second quarter 2026 financial results on July 28, 2026. The company will issue a press release before the market opens and will host a conference call at 8:00 a.m. ET to discuss business updates and financial results for the three-month reporting period ended June 30, 2026.
Conference Call Details
The conference call will be accessible by dialing toll-free (833) 461-5787 for domestic callers and (585) 542-9983 for international callers. The meeting ID is 768981187. A webcast will also be available via the Investor Relations section of the company’s website and will be archived for a period following the live event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The company focuses on Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins. Its corporate headquarters are in Waltham, Massachusetts, with manufacturing sites in the U.S., Estonia, Germany, Ireland, the Netherlands, and Sweden.
What key financial metrics will investors focus on during the Q2 2026 earnings call?
How might Repligen's global manufacturing footprint impact its Q2 2026 performance amid potential supply chain challenges?
What strategic updates or product launches could Repligen announce during the conference call?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
